Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
J Am Heart Assoc ; 10(1): e018108, 2021 01 05.
Article in English | MEDLINE | ID: mdl-33356406

ABSTRACT

Background Large-scale studies describing modern populations using an implantable cardioverter-defibrillator (ICD) are lacking. We aimed to analyze the incidence of arrhythmia, device interventions, and mortality in a broad spectrum of real-world ICD patients with different heart disorders. Methods and Results The UMBRELLA study is a prospective, multicenter, nationwide study of contemporary patients using an ICD followed up by remote monitoring, with a blinded review of arrhythmic episodes. From November 2005 to November 2017, 4296 patients were followed up. After 46.6±27.3 months, 16 067 episodes of sustained ventricular arrhythmia occurred in 1344 patients (31.3%). Appropriate ICD therapy occurred in 27.3% of study population. Patients with ischemic cardiomyopathy (hazard ratio [HR], 1.51; 95% CI, 1.29-1.78), dilated cardiomyopathy (HR, 1.28; 95% CI, 1.07-1.53), and valvular heart disease (HR, 1.94; 95% CI, 1.43-2.62) exhibited a higher risk of appropriate ICD therapies, whereas patients with hypertrophic cardiomyopathy (HR, 0.72; 95% CI, 0.54-0.96) and Brugada syndrome (HR, 0.25; 95% CI, 0.14-0.45) showed a lower risk. All-cause death was 13.4% at follow-up. Ischemic cardiomyopathy (HR, 3.09; 95% CI, 2.58-5.90), dilated cardiomyopathy (HR, 3.33; 95% CI, 2.18-5.10), and valvular heart disease (HR, 3.97; 95% CI, 2.25-6.99) had the worst prognoses. Delayed high-rate detection was enabled in 39.7% of patients, and single-zone programming occurred in 52.6% of primary prevention patients. Both parameters correlated with lower risk of first appropriate ICD therapy, with no excess risk of mortality. The rate of inappropriate shocks at follow-up was low (6%) and did not differ among type of ICD but was lower in SmartShock-capable devices. Conclusions Irrespective of the cause, contemporary ICD patients with heart failure-related disorders had a similar risk of ICD life-saving interventions and death. Current ICD programming recommendations still need to be implemented. Registration URL: https://www.clinicaltrials.gov; Unique identifier: NTC01561144.


Subject(s)
Defibrillators, Implantable , Electric Countershock , Tachycardia, Ventricular , Cohort Studies , Defibrillators, Implantable/adverse effects , Defibrillators, Implantable/classification , Defibrillators, Implantable/statistics & numerical data , Electric Countershock/adverse effects , Electric Countershock/instrumentation , Electric Countershock/methods , Electric Countershock/statistics & numerical data , Equipment Failure Analysis , Female , Heart Diseases/classification , Heart Diseases/complications , Heart Diseases/mortality , Heart Diseases/therapy , Heart Failure/complications , Heart Failure/mortality , Heart Failure/therapy , Humans , Male , Middle Aged , Mortality , Needs Assessment , Preventive Health Services/methods , Preventive Health Services/statistics & numerical data , Risk Assessment , Spain/epidemiology , Survival Analysis , Tachycardia, Ventricular/epidemiology , Tachycardia, Ventricular/therapy
SELECTION OF CITATIONS
SEARCH DETAIL
...